Blog

In this final installment, Dr. Siddique delivers a personal message.

In this second installment, Dr. Siddique discusses the future of ALS research and its implications for researchers and patients. We hope...

We're pleased to announce that Northwestern University-Feinberg School of Medicine has produced a three-part video series on ALS,...

The lead molecule under development by NDR for treating neuroinflammation is the retro-inverso thymopentin, TVALA®. The application for...

NDR is pleased to congratulate Dr. Sayuri Miyamoto and her co-workers Adriano Chaves-Filho, Rosangela Santos, Rodrigo Lima, Larissa...

Levamisole HCl and Zadaxin tested in two mouse models of ALS

NDR Inc is pleased to announce that Dr. Susanne Petri has joined our scientific group. Dr. Petri is an Associate Professor in the...

New drug development